US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 131.250
  • 0.0000.00%
Trading Mar 11 10:18 ET
13.96BMarket Cap-182.29P/E (TTM)

Intra-Cellular Therapies Key Stats

Intra-Cellular Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 222.463M--
--2025/Q1-- / 205.527M--
--2024/Q4199.223M / 193.286M--
Oct 30, 20242024/Q3175.375M / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 222.463M--
--2025/Q1-- / 205.527M--
--2024/Q4199.223M / 193.286M--
Oct 30, 20242024/Q3175.375M / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--

Unlock Free Earnings Estimates

Intra-Cellular Therapies Earnings Reports

Read more

Trending Stocks

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More